Global Extracorporeal CO2 Removal Market Growth 2023-2029
Extracorporeal CO2 Removal is the removal of carbon dioxide (CO2) from the bloodstream in people who have elevated levels of carbon dioxide as a result of respiratory failure.
LPI (LP Information)' newest research report, the “Extracorporeal CO2 Removal Industry Forecast” looks at past sales and reviews total world Extracorporeal CO2 Removal sales in 2022, providing a comprehensive analysis by region and market sector of projected Extracorporeal CO2 Removal sales for 2023 through 2029. With Extracorporeal CO2 Removal sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Extracorporeal CO2 Removal industry.
This Insight Report provides a comprehensive analysis of the global Extracorporeal CO2 Removal landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Extracorporeal CO2 Removal portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Extracorporeal CO2 Removal market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Extracorporeal CO2 Removal and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Extracorporeal CO2 Removal.
The global Extracorporeal CO2 Removal market size is projected to grow from US$ 21 million in 2022 to US$ 26 million in 2029; it is expected to grow at a CAGR of 26 from 2023 to 2029.
United States market for Extracorporeal CO2 Removal is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Extracorporeal CO2 Removal is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Extracorporeal CO2 Removal is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Extracorporeal CO2 Removal players cover ALung Technologies, XENIOS, Medtronic, ESTOR, Medica, Getinge and Aferetica, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Extracorporeal CO2 Removal market by product type, application, key manufacturers and key regions and countries.
Segmentation by type
Extracorporeal CO2 Machines
Segmentation by application
This report also splits the market by region:
Middle East & Africa
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Extracorporeal CO2 Removal market?
What factors are driving Extracorporeal CO2 Removal market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Extracorporeal CO2 Removal market opportunities vary by end market size?
How does Extracorporeal CO2 Removal break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?Please note:
The report will take approximately 2 business days to prepare and deliver.